Skip to main content
. Author manuscript; available in PMC: 2024 Feb 29.
Published in final edited form as: Am Heart J. 2022 May 30;251:101–114. doi: 10.1016/j.ahj.2022.05.019

Table 3.

Procedural characteristics in the selected trials

Case/Control, % STOPDAPT-2 ACS MASTER DAPTa TICO GLOBAL LEADERSa SMART- CHOICEa TWILIGHT-ACS REDUCE OPTIMIZEa RESETa
Radial approach 89.0/89.7 84.1/86.9 55/56 73.0/73.8 73.0/72.8 76.7/76.3 76.1/76.9 40/40 -
Staged approach 13.6/15.3 - - - - - - 6.7/7.3 -
Culprit vessels
 LAD 54.0/53.2 42.3/42.9 48/48 40.8/40.0 48.8/50.4 57.7/58.4 48.0/44.2 47.9/46.6 52.7/53.6
 LCx 13.8/13.1 22.1/23.0 19/19 24.9/25.3 21.6/19.9 32.6/32.9 19.5/22.0 23.4/24.3 21.0/19.2
 Left main 1.3/0.9 3.9/4.0 3/2 2.0/2.2 1.2/1.9 5.2/5.1 1.3/0.8 1.2/1.5 0/0
 RCA 30.8/32.7 30.5/28.8 30/31 31.3/31.5 28.2/27.8 34.9/33.9 31.2/33.0 27.6/27.7 26.3/27.1
 Bypass graft 0.1/0.1 1.3/1.3 - 0.9/1.0 - - - - -
Bifurcation lesion 26.8/26.4 3.6/4.4 14/15 11.5/11.7 13.3/12.1 12.5/12.6 - 14.7/14.9 -
Total occlusion 3.2/3.0 - - - - 5.6/6.1 26.9/24.3 4.2/3.6 -
Target lesions, mean 1.27/1.28 1.29/1.32 1.23/1.24 1.29/1.30 1.24/1.26 1.5/1.5 - 1.32/1.33 1.27/1.27
Multivessel treatment 16.7/18.8 25.2/27.8 17/18 14.2/14.7 22.5/24.6 - - 25.3/26.5 22.0/23.4
IVUS 87.3/86.2 - - - 25.0/27.2 - - - -
OCT 13.6/14.9 - - - - - - - -
Stents placed, mean 1.40/1.41 1.74/1.76 1.37/1.37 1.52/1.54 - - 1.20/1.21 1.6/1.6 -
Stent diameter, mm 3.01/3.02 3.00/2.99 3.13/3.14 3.0/3.0 - 2.9/2.9 - 2.7/2.7 3.18/3.17
Stent length, mm 34.3/34.6 39.3/39.7 35/35 24.3/24.3 38.0/37.8 40.5/39.8 23.0/23.0 - 22.7/22.9
a

Demographics and comorbidities of the entire sample, including all silent ischemia, stable angina, and acute coronary syndrome

Abbreviations: IVUS = intravascular ultrasound; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; OCT = optical coherence tomography; RCA = right coronary artery